Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cg0070 (1 trial)
nivolumab (opdivo) (1 trial)
Urinary Bladder Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (2 total)